Empagliflozin treatment in patients with GSD Type Ib | Webinar
Background:
Recently two reports have been published about off-label experimental empagliflozin treatment in GSD Ib patients.
When:
15 September 2020 at 16:00-17:30 CEST
Target Audience:
Health care professionals and patients
The Aims of the Webinar are:
1. To inform about the treatment
2. To share experiences
3. To discuss the next steps
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_Ee9CPmRNTlmiqJVMw9PXhg
More info: Webinar Info